Syndax Reports Third Quarter 2024 Financial Results and Provides Business Update
Hand-out
Press Releases
Syndax Pharmaceuticals, Inc.  
November 5, 2024

Syndax Reports Third Quarter 2024 Financial Results and Provides Business Update

– New revumenib and Niktimvo™ clinical data will be highlighted at 66th ASH Annual Meeting –

avatar profile Olean Times Herald

Olean Times Herald


Local & Social